Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) Tops Q2 EPS by 3c, Reaffirms Guidance

August 7, 2019 7:01 AM
Teva Pharma (NYSE: TEVA) reported Q2 EPS of $0.60, $0.03 better ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Hot Earnings

Next Articles